Before anti-VEGF medications like Avastin (bevacizumab) and Lucentis (ranibizumab), patients with age-related macular degeneration (AMD) had much worse outcomes, a new study found.

The US Food and Drug Administration (FDA) has approved a new medication to treat chronic obstructive pulmonary disease (COPD).

The US Food and Drug Administration (FDA) has approved a new opioid with abuse-deterrent properties.

Countless studies have evaluated specific interventions to manage weight. But a new study may have found an intervention that will effectively prevent weight gain.

The first generic version of Crestor (rosuvastatin) has received approval from the US Food and Drug Administration (FDA).

The US Food and Drug Administration (FDA) has approved Nuplazid (pimavanserin) tablets to treat hallucinations and delusions in patients with Parkinson's disease.

In a new study, researchers took a closer look at the relationship between statins, cholesterol and colorectal cancer.

Over the last 30 years, obesity prevalence has increased in all age groups, a new study found. That new study looked at the trends after recent efforts to decrease obesity.

Certain nutritional supplements may help antidepressants do their job better in patients with depression, a new study found.

In patients with coronary artery disease, the Mediterranean diet may reduce heart attack and stroke risk, a new study found.